Psychedelic researchers are engaged in heated debate over whether the mind-altering effects of the drugs are necessary for realizing their therapeutic potential.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Jun 22
Ebola update, World Cup heat risks, dad brains
In this episode of Science Quickly, we start with a quick update on the Ebola outbreak surging in parts of Africa. Host Rachel Feltman is then joined by Scientific American’s senior desk editor for life science Andrea Thompson to discuss what rising temperatures mean for the FIFA ... Show More
13m 10s
Jun 19
How common viruses could quietly raise your cancer risk
In this episode of Science Quickly, one of SciAm’s Young American Scientists, biologist Jaye Gardiner, explores how common viral infections may raise cancer risk—not just through genetic mutations but by reshaping the body’s “extracellular matrix” of molecules that support cells ... Show More
15m 34s
Oct 2024
Are psychedelics breaking science?
Drugs like ecstasy and mushrooms have shown promise as mental health treatments, but they’re also exposing some major cracks in how scientists study the brain.
Guests: Jonathan Lambert, science journalist; Boris Heifets, professor at Stanford University of Medicine; Amy Mcguire, ... Show More
24m 40s